Pub. Date : 2014 Feb
PMID : 24202668
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Cabozantinib, a targeted agent against MET and vascular endothelial growth factor receptor-2, has shown promising results and could become the first targeted therapy to be approved for castration-resistant prostate carcinoma. | cabozantinib | kinase insert domain receptor | Homo sapiens |